Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02011581

Acronym

24Hr

Enrollment

Registered

2013-12-13

Start date

2011-10-31

Completion date

2014-03-31

Last updated

2015-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Keywords

Overweight

Brief summary

The purpose of this research study is to learn more about how our body produces sugar, breaks down fat for fuel, and makes insulin (the major hormone that controls the production of blood sugar and fat breakdown) during a 24-hour day and how body fat and muscle are involved in these processes.

Detailed description

The purpose of this study is to determine whether there are diurnal differences in postprandial beta-cell function and hepatic insulin sensitivity and the factors that influence these metabolic functions, including insulin signaling, adipose tissue and systemic inflammation, nicotinamide phosphoribosyltransferase (NAMPT)-mediated nicotinamide adenine dinucleotide(NAD) biosynthesis, and sirtuin (silent mating type information regulation 2 homolog 1 (SIRT1)) in overweight human subjects.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* Females * 18-55 years old * BMI between 25.0-29.9 kg/m2 * Must be sedentary (regular exercise \<1hour/week or \<2 times/week

Exclusion criteria

* Regular exercise (\>1hour/week or \>2 times/week) * Diabetes * Severe organ dysfunction * Smokers * Severe hypertriglyceridemia (\>300 mg/dl) * Medications that may alter the results of the study * Pregnant * Breastfeeding

Design outcomes

Primary

Measure	Time frame	Description
Determine postprandial beta-cell function (insulin secretion) after ingesting breakfast and dinner meals.	24 hours	Postprandial pancreatic beta-cell function will be evaluated by using a mixed meal labelled with stable isotope tracers, in conjunction with stable isotope tracer infusion. Metabolic outcomes from the breakfast meal will be compared with values obtained after dinner.
Determine postprandial hepatic insulin sensitivity (suppression of endogenous glucose production) after ingesting breakfast and dinner meals.	24 hours	Postprandial pancreatic hepatic insulin sensitivity will be evaluated by using a mixed meal labelled with stable isotope tracers, in conjunction with stable isotope tracer infusion. Metabolic outcomes from the breakfast meal will be compared with values obtained after dinner.

Secondary

Measure	Time frame	Description
Determine whether there is diurnal variability in muscle insulin signaling	24 hours	This muscle samples will be obtained two times (every 12 hours for 24 hours)to assess NAMPT and NAD+ concentrations, SIRT1 activity, and factors involved in insulin signaling.
Determine whether there is diurnal variability in adipose tissue and systemic inflammation.	24 hours	Subcutaneous adipose tissue samples will be obtained four times (every 6 hours for 24 hours) to evaluate NAMPT and NAD+ concentrations, SIRT1 activity, and markers of inflammation.
Determine whether there is diurnal variability in NAMPT-mediated NAD+ biosynthesis and SIRT1.	24 hours	Blood samples will be obtained at regular intervals for 24 hours to evaluate; 1)plasma free fatty acids (FFA), glucose and insulin concentrations, 2)NAMPT and NAD+ concentrations, 3)SIRT1 activity,and 4)systemic markers of inflammation (C-reactive protein and interleukin (IL) -6).

Countries

United States

Outcome results